Pks‐positive Escherichia coli in tumor tissue and surrounding normal mucosal tissue of colorectal cancer patients

Toshimitsu Miyasaka,Takeshi Yamada,Kay Uehara,Hiromichi Sonoda,Akihisa Matsuda,Seiichi Shinji,Ryo Ohta,Sho Kuriyama,Yasuyuki Yokoyama,Goro Takahashi,Takuma Iwai,Kohki Takeda,Koji Ueda,Shintaro Kanaka,Ryuji Ohashi,Hiroshi Yoshida
DOI: https://doi.org/10.1111/cas.16088
IF: 5.7
2024-02-01
Cancer Science
Abstract:Polyketide synthetase (pks)‐positive Escherichia coli (pks+ E. coli), which has been reported to contribute to colorectal carcinogenesis, is more abundant in Stage I tumors than normal mucosal tissue and Stages II–IV tumors. Furthermore, a high level of pks+ E. coli in tumor tissue is associated with a favorable prognosis of prognosis in multivariable Cox regression analysis. A significant association exists between the gut microbiome and colorectal carcinogenesis, as well as cancer progression. It has been reported that Escherichia coli (E. coli) containing polyketide synthetase (pks) island contribute to colorectal carcinogenesis by producing colibactin, a polyketide‐peptide genotoxin. However, the functions of pks+ E. coli in initiation, proliferation, and metastasis of colorectal cancer (CRC) remain unclear. We investigated the clinical significance of pks+ E. coli to clarify its functions in CRC. This study included 413 patients with CRC. Pks+ E. coli of tumor tissue and normal mucosal tissue were quantified using droplet digital PCR. Pks+ E. coli was more abundant in Stages 0–I tumor tissue than in normal mucosal tissue or in Stages II–IV tumor tissue. High abundance of pks+ E. coli in tumor tissue was significantly associated with shallower tumor depth (hazard ratio [HR] = 5.0, 95% confidence interval [CI] = 2.3–11.3, p
oncology
What problem does this paper attempt to address?